losartan has been researched along with Glomerulonephritis, Membranous in 4 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with lisinopril and losartan in nephrotic patients with idiopathic membranous nephropathy results in similar (and significant) effects on renal function, hypoalbuminaemia, proteinuria and blood pressure." | 9.14 | Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome. ( Filiopoulos, V; Georgoulias, C; Kosmadakis, G; Michail, S; Tentolouris, N, 2010) |
| "Treatment with lisinopril and losartan in nephrotic patients with idiopathic membranous nephropathy results in similar (and significant) effects on renal function, hypoalbuminaemia, proteinuria and blood pressure." | 5.14 | Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome. ( Filiopoulos, V; Georgoulias, C; Kosmadakis, G; Michail, S; Tentolouris, N, 2010) |
| "Treatment with canagliflozin increased the proportion of Th1 cells by 2." | 1.72 | Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy. ( Li, J; Lin, Y; Liu, H; Lv, X; Ma, G; Shao, X; Wang, J; Yu, P; Zhang, L; Zhou, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, X | 1 |
| Wang, J | 1 |
| Zhang, L | 1 |
| Shao, X | 1 |
| Lin, Y | 1 |
| Liu, H | 1 |
| Ma, G | 1 |
| Li, J | 1 |
| Zhou, S | 1 |
| Yu, P | 1 |
| Kosmadakis, G | 1 |
| Filiopoulos, V | 1 |
| Georgoulias, C | 1 |
| Tentolouris, N | 1 |
| Michail, S | 1 |
| Xu, ZG | 1 |
| Lanting, L | 1 |
| Vaziri, ND | 1 |
| Li, Z | 1 |
| Sepassi, L | 1 |
| Rodriguez-Iturbe, B | 1 |
| Natarajan, R | 1 |
| Yoshimura, J | 1 |
| Kato, S | 1 |
| Tamaki, K | 1 |
| Kohno, K | 1 |
| Kaneyuki, U | 1 |
| Maeda, M | 1 |
| Saikusa-Itoh, Y | 1 |
| Hayashida, A | 1 |
| Iida, S | 1 |
| Suefuji, H | 1 |
| Okuda, S | 1 |
1 trial available for losartan and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inh | 2010 |
3 other studies available for losartan and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Canagliflozin reverses Th1/Th2 imbalance and promotes podocyte autophagy in rats with membranous nephropathy.
Topics: Animals; Autophagy; Canagliflozin; Glomerulonephritis, Membranous; Losartan; Podocytes; Rats; Renal | 2022 |
Upregulation of angiotensin II type 1 receptor, inflammatory mediators, and enzymes of arachidonate metabolism in obese Zucker rat kidney: reversal by angiotensin II type 1 receptor blockade.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arachidonic Acid; Enzymes | 2005 |
Mesangiolytic glomerulopathy after radiotherapy and chemotherapy of gastric lymphoma.
Topics: Angiotensin II Type 1 Receptor Blockers; Antineoplastic Combined Chemotherapy Protocols; Combined Mo | 2007 |